NCT06311435 Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
| NCT ID | NCT06311435 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MaxWell Clinic, PLC |
| Condition | Long COVID |
| Study Type | INTERVENTIONAL |
| Enrollment | 224 participants |
| Start Date | 2024-03-15 |
| Primary Completion | 2026-03-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 224 participants in total. It began in 2024-03-15 with a primary completion date of 2026-03-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of specific blood RNA from patients with long COVID together and separately from the apparent health normal controls and other medical conditions that share the signs and symptoms of long COVID.
Eligibility Criteria
Inclusion Criteria: * Mentally capable of understanding and completing informed consent for the study. * Precipitants with a lab verified diagnosis of SARS-CoV-2 or clinician note/record that an appropriate rapid test for SARS-CoV-2 was positive. * To qualify for long COVID group participants will need to have new, persistent symptoms related to SARS-CoV-2 infection. iv. No one under the age of 18. Exclusion Criteria: * Subject is unable to provide informed consent. * Primary Investigator or Sub-Investigator determines the participant's ongoing medical complaints that began after 1 November 2019 are not related to SARS-COV-2 but another disease process.
Frequently Asked Questions
Who can join the NCT06311435 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Long COVID. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06311435 currently recruiting?
Yes, NCT06311435 is actively recruiting participants. Visit ClinicalTrials.gov or contact MaxWell Clinic, PLC to inquire about joining.
Where is the NCT06311435 trial being conducted?
This trial is being conducted at Iowa City, United States, Brentwood, United States, Brentwood, United States.
Who is sponsoring the NCT06311435 clinical trial?
NCT06311435 is sponsored by MaxWell Clinic, PLC. The trial plans to enroll 224 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.